BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 32703953)

  • 1. Hodgkin lymphoma.
    Connors JM; Cozen W; Steidl C; Carbone A; Hoppe RT; Flechtner HH; Bartlett NL
    Nat Rev Dis Primers; 2020 Jul; 6(1):61. PubMed ID: 32703953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma.
    Gobbi PG; Ferreri AJ; Ponzoni M; Levis A
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):216-37. PubMed ID: 22867814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Hodgkin lymphoma.
    Ansell SM; Armitage JO
    Mayo Clin Proc; 2006 Mar; 81(3):419-26. PubMed ID: 16529147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2016 Jun; 91(4):434-42. PubMed ID: 27001163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis.
    Piris MA; Medeiros LJ; Chang KC
    Pathology; 2020 Jan; 52(1):154-165. PubMed ID: 31699300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and staging of Hodgkin lymphoma].
    Ghesquières H
    Rev Prat; 2023 Jun; 73(6):617-620. PubMed ID: 37458549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2014 Jul; 89(7):771-9. PubMed ID: 24953862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2020 Aug; 95(8):978-989. PubMed ID: 32384177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2012 Dec; 87(12):1096-103. PubMed ID: 23151980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin Lymphoma: Diagnosis and Treatment.
    Ansell SM
    Mayo Clin Proc; 2015 Nov; 90(11):1574-83. PubMed ID: 26541251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies and antibody-drug conjugates in the treatment of Hodgkin lymphoma.
    Eichenauer DA; Engert A
    Eur J Haematol; 2014 Jul; 93(1):1-8. PubMed ID: 24750367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2018 May; 93(5):704-715. PubMed ID: 29634090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the initial management of Hodgkin's Lymphoma.
    Marri PR; Ansell SM
    Transfus Apher Sci; 2013 Aug; 49(1):12-8. PubMed ID: 23769695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma: an update on its biology with new insights into classification.
    Mani H; Jaffe ES
    Clin Lymphoma Myeloma; 2009 Jun; 9(3):206-16. PubMed ID: 19525189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel agents for the treatment of Hodgkin lymphoma.
    Dumaswala K; Mehta A
    Expert Rev Hematol; 2015 Oct; 8(5):659-67. PubMed ID: 26343891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for the treatment of Hodgkin lymphoma.
    Donato EM; Fernández-Zarzoso M; De La Rubia J
    Expert Rev Hematol; 2017 May; 10(5):417-423. PubMed ID: 28359170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
    Rueda Domínguez A; Alfaro Lizaso J; de la Cruz Merino L; Gumá I Padró J; Quero Blanco C; Gómez Codina J; Llanos Muñoz M; Martinez Banaclocha N; Rodriguez Abreu D; Provencio Pulla M
    Clin Transl Oncol; 2015 Dec; 17(12):1005-13. PubMed ID: 26497354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin lymphoma involving extranodal sites in head and neck: report of twenty-nine cases and review of three-hundred and fifty-seven cases.
    Akhtar S; Khafaga Y; Edesa W; Al-Mubarak M; Rauf MS; Maghfoor I
    Hematology; 2021 Dec; 26(1):103-110. PubMed ID: 33478377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
    Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
    Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.